汇宇制药：截至2025年半年报披露日，公司在海外累计已有25个产品获批上市

Core Viewpoint - The company, Huyou Pharmaceutical, has achieved significant milestones in its overseas market expansion, with 25 products approved for sale in 68 countries and regions by the mid-2025 report date [2]. Group 1: Overseas Market Expansion - As of the mid-2025 report date, the company has obtained approvals for 25 products in overseas markets [2]. - The company has established a presence in 68 countries and regions, indicating a broad international reach [2]. Group 2: Sales Strategy in Europe - The company's sales model in Europe primarily follows a self-operated approach, with seven subsidiaries established in key countries including the UK, Ireland, France, Germany, the Netherlands, Italy, and Portugal [2]. - A robust marketing system and extensive channel network have been developed to support sales in Europe [2]. - The company plans to accelerate the construction and depth of its direct sales network in Europe [2].